Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas
- 1 November 1996
- journal article
- review article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 8 (11) , 1054-1061
- https://doi.org/10.1097/00042737-199611000-00005
Abstract
Most cases of antibiotic-associated diarrhoea are due to Clostridium difficile or are enigmatic. Patients with C. difficile-associated disease are more likely to have colitis, severe disease and nosocomial acquisition. The preferred diagnostic test is a C. difficile toxin assay using a tissue culture assay or enzyme immunoassay. The usual treatment is withdrawal of the inducing agent, sometimes supplemented with oral vancomycin or metronidazole. Response rates approach 100%; the major complication is relapse. Major complications include toxic megacolon, devastating diarrhoea, pseudomembranous colitis and hypoalbuminemia. Antibiotic-associated diarrhoea with negative tests for C. difficile toxin is usually dose-related and responds to antibiotic withdrawal. European Journal of Gastroenterology & Hepatology 1996, 8:1054–1061Keywords
This publication has 0 references indexed in Scilit: